tiprankstipranks
Trending News
More News >
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market

Nurix Therapeutics (NRIX) Income Statement

Compare
524 Followers

Nurix Therapeutics Income Statement

Last quarter (Q3 2025), Nurix Therapeutics's total revenue was $7.89M, a decrease of -37.29% from the same quarter last year. In Q3, Nurix Therapeutics's net income was $-86.42M. See Nurix Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 54.55M$ 76.99M$ 38.63M$ 29.75M$ 17.82M
Gross Profit
$ -167.08M$ -112.16M$ -145.87M$ -86.68M$ -48.67M
Operating Expenses
$ 45.94M$ 42.90M$ 38.00M$ 31.20M$ 16.31M
Depreciation and Amortization
$ 8.02M$ 6.13M$ 4.15M$ 1.99M$ 2.18M
EBITDA
$ -205.01M$ -148.93M$ -179.72M$ -115.90M$ -62.80M
Operating Income
$ -213.03M$ -155.06M$ -183.87M$ -117.89M$ -64.98M
Other Income/Expenses
$ 19.73M$ 11.12M$ 3.51M$ 823.00K$ 1.21M
Pretax Income
$ -193.30M$ -143.95M$ -180.36M$ -117.06M$ -63.78M
Net Income
$ -193.57M$ -143.95M$ -180.36M$ -117.19M$ -43.24M
Per Share Metrics
Basic EPS
$ -2.88$ -2.65$ -3.71$ -2.73$ -2.76
Diluted EPS
$ -2.88$ -2.65$ -3.71$ -2.73$ -2.76
Weighted Average Shares Outstanding
67.12M 54.34M 48.61M 42.90M 15.67M
Weighted Average Shares Outstanding (Diluted)
67.12M 54.34M 48.61M 42.90M 15.67M
Currency in USD

Nurix Therapeutics Earnings and Revenue History